Sort
51,593 grants matching “hepatitis”
The Impact of HCV Treatment in HIV/HCV coinfected and HCV monoinfected Incarcerated Persons on HCV Elimination
$779,830David L Thomas · Johns Hopkins University · R01 · FY2021 · DA
Seq-Scope: Microscopic Examination of Spatial Single Cell Transcriptome in Cell and Tissue Senescence
$779,599Jun Hee Lee · University Of Michigan At Ann Arbor · UH3 · FY2024 · CA
Developmental Core
$779,565Herman F. Staats · Duke University · P30 · FY2020 · AI
Neurodegeneration and Brain Function in Aging with HIV and Parkinson's Disease
$779,527Tilman Schulte · Sri International · R01 · FY2017 · AA
Characterization of silently HBV-infected hepatocytes in HIV co-infection
$779,416Ashwin Balagopal · Johns Hopkins University · R01 · FY2021 · AI
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence
$779,187T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Mechanisms of Therapy and Model Development in Hepatitis C and Liver Diseases
$779,187T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Bupropion for smoking cessation during pregnancy
$779,099Gary D Hankins · University Of Texas Med Br Galveston · R01 · FY2014 · DA
Physiologic Consequence of Genetic Variation
$778,813Richard M Watanabe · University Of Southern California · R01 · FY2017 · DK
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$778,661Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Pathogenesis of Hepatitis B Virus in Transgenic Mice
$777,980Francis Vincent Chisari · Scripps Research Institute, The · R01 · FY2006 · CA
Changes in Bone Quality, Sarcopenia and Fat Distribution in HIV/HCV Patients after HCV Therapy
$777,720Vincent Lo Re · University Of Pennsylvania · R01 · FY2021 · AI
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease
$777,501D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UH3 · FY2024 · TR
A Hybrid Implementation-Effectiveness Study of the Pharmacist, Physician, and Patient Navigator Collaborative Care Model to cure Hepatitis C among persons who use drugs with housing insecurity
$777,497Judith Tsui · University Of Washington · R01 · FY2025 · DA
Colorado Center for Childhood Liver Disease Research and Education
$777,405Ronald J Sokol · University Of Colorado Denver · U01 · FY2009 · DK
Nucleic Acid Footprinting and development of small molecule antagonists
$777,378Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$777,308Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2017 · DA
Administrative Core
$777,219Chloe L Thio · Johns Hopkins University · U19 · FY2025 · AI
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use
$777,196Amy Caroline Justice · Yale University · U24 · FY2011 · AA
Mechanisms of Chronic Hepatitis B Infection and Therapeutic Vaccines
$777,154David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2011 · AI
Post-transcriptional regulation of LDLR
$777,112Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2024 · HL
HEPATITIS C: STUDIES OF IMMUNITY AND PATHOGENESIS
$777,103Rockefeller University · U19 · FY2004 · AI
Promoting remote and secondary risk prevention services in rural settings
$776,927Mai Tuyet Pho · University Of Chicago · R01 · FY2025 · DA
Multi Ancestry Whole Genome Sequencing Analyses of MASLD with Functional Follow Up
$776,863Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2025 · DK
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection
$776,825Neel Rajnikant Gandhi · Emory University · R01 · FY2022 · AI